NCT00453050View on ClinicalTrials.gov

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2009

Conditions

Melanoma (Skin)Metastatic Cancer

Interventions

DRUG

imiquimod

DRUG

indocyanine green solution

OTHER

flow cytometry

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

Trial Locations (1)

74135-2512

Oklahoma University Cancer Institute, Tulsa

All Listed Sponsors

lead

University of Oklahoma

OTHER

NCT00453050 - Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin | Biotech Hunter | Biotech Hunter